The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update

Keyphrases

• Epidemiology 100%
• Pseudomonas Aeruginosa (P. aeruginosa) 100%
• Pseudomonas Aeruginosa Infection 100%
• Epidemiological Study 33%
• Clinical Scenarios 33%
• Cystic Fibrosis 33%
• Biofilm Formation 33%
• Antimicrobial Therapy 33%
• Gram-negative Bacteria 33%
• Pneumonia Infection 33%
• Antimicrobial Resistance 33%
• Combination Therapy 33%
• Common Cause 33%
• Nosocomial Infection 33%
• Virulence Mechanisms 33%
• Bacterial Pathogens 33%
• Severe Infection 33%
• Infections In Immunocompromised Hosts 33%
• Increasing Trends 33%
• Antipseudomonal Antibiotics 33%
• P. Aeruginosa Infection 33%
• Multidrug-resistant Pseudomonas Aeruginosa (MDRPA) 33%
• Infection Focus 33%
• Quorum Sensing 33%
• Multidrug-resistant Isolates 33%
• Secreted Toxin 33%
• Structural Lung Disease 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Pseudomonas aeruginosa 100%
• Pseudomonas Infection 100%
• Infection 60%
• Combination Therapy 20%
• Hospital Infection 20%
• Antibiotics 20%
• Lung Disease 20%
• Cystic Fibrosis 20%
• Infectious Agent 20%
• Antimicrobial Therapy 20%
• Immunocompromised Patient 20%
• Antimicrobial Resistance 20%
• Amoxicillin 20%